Food coloring additives & T2D, automated insulin delivery systems in T2D, and more!

About this episode

This episode discusses the impact of food coloring additives on type 2 diabetes and reviews automated insulin delivery systems among other topics.

Welcome to the latest episode (June 2026) of Diabetes Core Update , where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic disease. This month on DOC Update : Shah S, et al. " Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort Diabetes Care . 2026;49(6):1067–1077. doi.org/10.2337/dc25-2727 Hespanhol L, et al. " Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis ." Diabetes Care . 2026;49(6):1134–1143. doi.org/10.2337/dc25-2435 Tatum K, et al. " Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer ." JAMA . Published Online: May 11, 2026 2026;9;(5):e2612133. doi:10.1001/jamanetworkopen.2026.12133 Winkler C, et al. " Screening Children for Early-Stage Type 1 Diabetes ." JAMA . Published Online: May 21, 2026 doi:10.1001/jama.2026.6085 Würtz Yazdanfard P, Kosjerina V, Wood-Kurland H et al. " Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024) " Lancet . Volume 66, 101716, July 2026. doi:10.1016/j.lanepe.2026.101716 Horn D, Aronne L, Wharton S…

People in this episode

Hosts: Neil Skolnik, M.D., John Russell, M.D.

Topics covered

• food coloring additives
• type 2 diabetes
• automated insulin delivery systems
• GLP-1 receptor agonists
• breast cancer
• screening for diabetes
• semaglutide

Keywords

• type 2 diabetes
• food coloring
• automated insulin delivery
• GLP-1 receptor agonists
• breast cancer
• screening
• semaglutide

Mentioned in this episode

Organizations: American Diabetes Association

Books & works: Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort, Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis, Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer, Screening Children for Early-Stage Type 1 Diabetes, Effectiveness and Safety of Semaglutide in Type 1 Diabetes: A Danish Nationwide Cohort Study (2018–2024), Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN)

More episodes of DOC Updates

• Special Edition: Hypertension Part 2—Advanced Hypertension Management: Uncontrolled and Resistant Hypertension and the Importance of Aldosterone · September 8, 2026 · 40 min
• Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) · September 3, 2026 · 23 min
• Special Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight Maintenance · August 24, 2026 · 32 min
• Special Edition: What's Next—The Role of Health Systems in Managing CKD Associated with T1D & T2D · August 17, 2026 · 33 min
• Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more! · August 10, 2026 · 36 min
• Impact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more! · August 10, 2026 · 32 min